The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
July 7th 2025
Y-90 resin microspheres offer a new option for patients with liver cancer for the treatment of unresectable hepatocellular carcinoma.
Pediatric Hepatitis Levels Remain Consistent With Pre-Pandemic Levels
July 12th 2022Hepatitis-associated emergency department visits and hospitalizations, liver transplantations, and adenovirus stool testing results in pediatric patients were not found to increase during the COVID-19 pandemic.
Read More
Hepatitis Awareness Month: Help Your Patients Live(r) Longer
Many of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.
Read More
Hepatitis C Is Widespread but Rarely Treated in Postpartum Medicaid Beneficiaries With OUD
April 12th 2022Getting an appointment with an infectious diseases specialist, particularly after giving birth and while managing a chronic disorder, such as substance use, is difficult, investigators say.
Read More